Skip to main content

Table 1 Baseline characteristics of smear-negative presumptive TB patients, overall and by whether they had received an Xpert® MTB/RIF

From: Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study

Characteristic

 

No XP

XP

Total

P-value

Total (n [%])

 

236 (57.4)

175 (42.6)

411 (100)

 

Age (mean [SD])

 

38 (9)

40 (11)

39 (10)

0.10

Female sex (n [%])

 

133 (56.4)

99 (56.6)

232 (56.4)

0.97

CD4 count (median [IQR])*

 

274 (147, 422)

275 (179, 478)

275 (162, 426)

0.73

ART at TB treatment initiation (n [%])

 

116 (49.2)

89 (50.9)

205 (49.9)

0.73

Prior TB treatment (n [%])

 

34 (14.4)

29 (16.6)

63 (15.3)

0.55

Symptomatology at presentation (n [%])

Cough

228 (96.6)

173 (98.9)

401 (97.6)

0.14

Fever

169 (71.6)

124 (70.9)

293 (71.3)

0.87

Night sweats

112 (47.5)

88 (50.3)

200 (48.7)

0.57

Weight loss

80 (33.9)

63 (36)

143 (34.8)

0.66

Anorexia

113 (47.9)

84 (48)

197 (47.9)

0.98

Chest pain

64 (27.1)

57 (32.6)

121 (29.4)

0.23

  1. IQR interquartile range, n number, SD standard deviation, TB tuberculosis, XP Xpert® MTB/RIF
  2. *On 200, 152 and 352 patients, respectively